Upgrade to SI Premium - Free Trial

Bio-Rad Labs (BIO) Tops Q2 EPS by 37c

August 7, 2018 4:51 PM

Bio-Rad Labs (NYSE: BIO) reported Q2 EPS of $1.64, $0.37 better than the analyst estimate of $1.27. Revenue for the quarter came in at $575.9 million versus the consensus estimate of $548.43 million.

For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.

Categories

Earnings

Next Articles